Cooper Companies, Inc.
COONasdaqOphthalmic GoodsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 15/3040% below fair value
$58.88−1.45 (-2.40%)
Close on Nov 20, 2026Market cap $11.20BP/E 20.1Yield –
Cooper Companies CooperSurgical & Origio Sponsored Studies Started by Year
Periods
Cooper Companies CooperSurgical & Origio Sponsored Studies Started: 0 in FY2026. That is the lowest of the 10 years on record here.
Latest, FY2026
0
Period ended Oct 31, 2026 (CY2026)
Change on a year earlier
–
0 in FY2025
History
10 years
Since FY2017
Sources
1
U.S. National Library of Medicine — ClinicalTrials.gov Registry
Where the FY2026 figure comes from
Source: U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | CooperSurgical & Origio Sponsored Studies Started | Year on year | Source |
|---|---|---|---|---|
| FY2026CY2026 | Oct 31, 2026 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2025CY2025 | Oct 31, 2025 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2024CY2024 | Oct 31, 2024 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2023CY2023 | Oct 31, 2023 | 0 | -100.0% | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2022CY2022 | Oct 31, 2022 | 1 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2021CY2021 | Oct 31, 2021 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2020CY2020 | Oct 31, 2020 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2019CY2019 | Oct 31, 2019 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2018CY2018 | Oct 31, 2018 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
| FY2017CY2017 | Oct 31, 2017 | 0 | – | U.S. National Library of Medicine — ClinicalTrials.gov Registry ↗ |
Cite this data
StockData. (2026). Cooper Companies CooperSurgical & Origio Sponsored Studies Started, annual FY2017–FY2026 [Data set]. Compiled from Cooper Companies SEC filings and investor materials. https://stockdatahq.com/stocks/coo/kpis/ct-csi-studies-started
See every metric in the Cooper Companies KPI table. Data updated Nov 18, 2026.
See a number that looks wrong?